EFFECT OF HONEY ON THE INCIDENCE OFCANCER THERAPY-INDUCED BONE MARROW SUPPRESSION IN CHILDREN WITH MALIGNANCIES
Nouran Abdel Aal Hassanen;
Abstract
T
his prospective cross-over analytical study was conducted at the Hematology/Oncology Clinic, Children’s Hospital, Ain Shams University. The study included 60 of cancer patients their Inclusion criteria were those aged (1-18) years old, of both sexes, having malignancy & receiving regular cancer therapy& exclusion criteria was Cancer patients with diabetes mellitus.
The recruited cases were randomly assigned to one of two main groups:
Group (A):
Included 30 patients, who received their regular chemotherapy without honey for 3 months (protocol B), followed by 3 months with honey intake in a dose of 2ml/Kg/dose twice weekly for 3 months (protocol A), beside their regular chemotherapy.
They were 30 children (14 males and 16 females) whose mean age was (5.8±3.18) years.
Group (B):
Included 30 patients, who received honey in a dose of 2ml/Kg/dose twice weekly for 3 months (protocol A), followed by 3 months without honey (protocol B), beside their regular chemotherapy.
They were 30 children (12 males and 18 females) whose mean age was (5.9±3.19) years.
There was no statistical difference among the 2 studied groups as regards Age, sex, the sex, age, weight, age at diagnosis & duration of chemotherapy
his prospective cross-over analytical study was conducted at the Hematology/Oncology Clinic, Children’s Hospital, Ain Shams University. The study included 60 of cancer patients their Inclusion criteria were those aged (1-18) years old, of both sexes, having malignancy & receiving regular cancer therapy& exclusion criteria was Cancer patients with diabetes mellitus.
The recruited cases were randomly assigned to one of two main groups:
Group (A):
Included 30 patients, who received their regular chemotherapy without honey for 3 months (protocol B), followed by 3 months with honey intake in a dose of 2ml/Kg/dose twice weekly for 3 months (protocol A), beside their regular chemotherapy.
They were 30 children (14 males and 16 females) whose mean age was (5.8±3.18) years.
Group (B):
Included 30 patients, who received honey in a dose of 2ml/Kg/dose twice weekly for 3 months (protocol A), followed by 3 months without honey (protocol B), beside their regular chemotherapy.
They were 30 children (12 males and 18 females) whose mean age was (5.9±3.19) years.
There was no statistical difference among the 2 studied groups as regards Age, sex, the sex, age, weight, age at diagnosis & duration of chemotherapy
Other data
| Title | EFFECT OF HONEY ON THE INCIDENCE OFCANCER THERAPY-INDUCED BONE MARROW SUPPRESSION IN CHILDREN WITH MALIGNANCIES | Other Titles | تأثير العسل على حدوث تثبيط نخاع العظام الناجم عن العلاج الكيميائي في الأطفال الذين يعانون من الأورام الخبيثة | Authors | Nouran Abdel Aal Hassanen | Issue Date | 2014 |
Recommend this item
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.